OACCWNasdaqBlank ChecksUS GAAP · USD

Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a U.S.-based special purpose acquisition company formed to identify and combine with a business in the life sciences sector. As a blank-check company, it does not operate a commercial product business itself; instead, it holds IPO proceeds in trust while searching for a target acquisition.

Operating profit (EBIT)-1.2m USD
Net income7.3m USD

Fiscal year 2025 · change from previous year

Development 2025–2025

-1.25-1.00-0.75-0.50-0.250.00m USD2025: EBIT -1.2 m USD2025-1.2
RevenueOperating profit (EBIT)
Ask Clarifo about Oaktree Acquisition Corp. III Life Sciences

Business

Share of revenue
SPAC vehicle100 %

Capital-raising shell company formed to complete a future business combination.

Customers

The company does not sell products or services to end customers in the ordinary course. Its economic counterparties are public shareholders, warrant holders, the sponsor, underwriters, and ultimately a future merger target in the life sciences sector.

Public shareholders

Invest in the SPAC units and shares for exposure to a future acquisition transaction.

Sponsor and affiliates

Provide private placement capital, administrative services, and transaction support.

Future acquisition target

A life sciences company that may merge with the SPAC to access public markets.

Underwriters

Facilitate the IPO and earn underwriting fees tied to the capital raise.

Strategy

The company’s strategy is to identify and complete a business combination with a life sciences target within its permitted timeframe. It also manages the trust account, sponsor support arrangements, and public-company compliance while preserving optionality for a transaction.

Complete a business combinationShort term

The SPAC has no operating business until it merges with a target.

Manage liquidity and working capitalShort term

Public-company and transaction costs continue before any merger closes.

Preserve shareholder value through structureMedium term

Redemptions and trust-account mechanics affect the capital available for a deal.

Geography

The company is incorporated and headquartered in the United States, and its securities are issued through U.S. capital markets. Its operating footprint is currently limited to the U.S. while it searches for a target, though a future business combination could introduce international exposure depending on the acquisition.

Risks

The main risk is that the company may fail to complete a business combination before its deadline, which could force liquidation. It also faces financing, redemption, and execution risks typical of SPACs, along with accounting complexity around warrants and redeemable shares.

Sorted by severity
Business combination deadline riskCritical

If no transaction closes by the deadline, the company may liquidate and dissolve.

Exposure: All shareholders

Redemption riskHigh

Shareholder redemptions can materially reduce cash available for an acquisition.

Exposure: Trust account and deal financing

Financing riskHigh

The company may need sponsor or third-party funding to meet working capital needs.

Exposure: Operating liquidity

Transaction execution riskHigh

A target may not be found, negotiated, approved, or closed on acceptable terms.

Exposure: Acquisition process

Accounting and valuation riskMedium

Warrants and redeemable shares require fair-value and classification judgments.

Exposure: Financial statements

Ask Clarifo about Oaktree Acquisition Corp. III Life Sciences

Accounting

Judgemental items
Warrant instruments

Public and private placement warrants are evaluated under derivative and equity-classification guidance, affecting balance sheet presentation and fair-value treatment.

Impact: Can change reported equity, liabilities, and earnings volatility

Class A redeemable share classification

Redeemable shares must be presented and measured based on redemption features, which affects permanent equity versus temporary equity.

Impact: Affects balance sheet structure and shareholder equity

Trust account interest income

Interest earned on marketable securities in the trust account is the main recurring income item before a merger.

Impact: Drives reported net income despite no operating business

Going-concern assessment

Management must assess whether financing and a business combination are achievable before the deadline.

Impact: Can influence disclosure and liquidity presentation

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026